A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
Aulos Bioscience, Inc.
Neonc Technologies, Inc.
BicycleTx Limited
Roswell Park Cancer Institute
University of Pittsburgh
Maastricht University Medical Center
Bolt Biotherapeutics, Inc.
Incyte Corporation
Incyte Corporation
Providence Health & Services
Oslo University Hospital
ImmunityBio, Inc.
Purple Biotech Ltd.
Compugen Ltd
University of Washington
The Netherlands Cancer Institute
Nektar Therapeutics
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Incyte Corporation
Genocea Biosciences, Inc.
Incyte Corporation
Washington University School of Medicine
MultiVir, Inc.
Celldex Therapeutics